Rand Paul's Biosimilar Drug Bill Could Cut Costs, Speed Patient Access
News
Archived
•
July 31, 2026
•
The Expedited Access to Biosimilars Act enables FDA approval of pharmaceutically equivalent biologic medications.
Source: https://reason.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


